Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib and NB-UVB for Generalized Vitiligo
NCT06768840Phase 3Recruiting
- Sponsor
- South Valley University
- Start
- Oct 2024
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of baricitinib in generalized vitiligo, sponsored by South Valley University. Started Oct 2024; status: recruiting.
02
Drugs
baricitinib
03
Conditions
generalized vitiligo
Beyond the preview
Go deeper on NCT06768840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06768840.